NEW YORK (GenomeWeb) – Caprion's acquisition of ImmuneHealth's immune monitoring laboratory is key to bolstering its ImmuneCarta immune monitoring business, a company official told GenomeWeb this week.

The purchase gives Caprion a European footprint, which will allow it to service clinical trials there that require analysis of fresh blood or tissue samples, said Martin LeBlanc, the company's president and CEO. This is particularly important for trials in immune oncology, he said, which is a substantial and growing portion of Caprion's business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.